Q2 2025 Milestone Scientific Inc Earnings Call Transcript
Key Points
- Milestone Scientific Inc (MLSS) reported a 25% revenue growth in Q2 2025, reaching $2.3 million, primarily driven by the dental segment.
- The company secured Medicare Part B payment rate assignment under CPT code 0770T in multiple jurisdictions, enhancing reimbursement pathways for the CompuFlo Epidural System.
- International sales more than doubled, contributing significantly to the revenue increase, with international revenue accounting for 48% of total sales.
- The company has strengthened its leadership team with the appointment of Eric Hines as CEO and Jason Papes as Senior Vice President, Global Head of Sales and Marketing, both bringing extensive experience in scaling operations.
- Milestone Scientific Inc (MLSS) maintained a solid balance sheet with $1.3 million in cash and no long-term debt, indicating strong financial management.
- Despite the Medicare Part B coverage, adoption of the CompuFlo system in the medical segment has been slow, with only 5 to 10 clinics actively using the product.
- Domestic dental sales were relatively flat, indicating challenges in growing the US market despite international success.
- The company reported a loss from operations of approximately $1.5 million for Q2 2025, although this was a decrease from the previous year.
- Research and development expenses decreased significantly, which could impact future innovation and product development.
- The company faces challenges with tariffs and international market dynamics, which could affect future growth and profitability.
Good morning, everyone, and welcome to the Milestone Scientific second-quarter 2025 financial results and business update conference call. (Operator Instructions) Please note, this conference is being recorded.
I will now turn the conference over to your host, David Waldman of Crescendo Communications. David, the floor is yours.
Thank you, Jenny. Good morning, and thank you all for joining Milestone Scientific's second-quarter 2025 financial results conference call. On the call with us today are Neal Goldman, Chairman; Eric Hines, Chief Executive Officer; and Keisha Harcum, Vice President, Finance Milestone Scientific.
The company issued a press release yesterday afternoon containing second quarter 2025 financial results, which is also posted on the company's website. If you have any questions after the call, would like any additional information about the company, please contact Crescendo Communications at (212) 671-1020.
Company's management will now provide prepared
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
